YANG ZHANG
Acupuncture at Morse Ave, Sunnyvale, CA
License number
California AC16339
Category
Acupuncture
Type
Acupuncturist
Address
Address
1111 Morse Ave SPC 227, Sunnyvale, CA 94089
Phone
(408) 781-8017
Professional information
Yang Zhang - Sunnyvale, CA
Work:
Menlo Park Academy - Westlake, OH
Volunteer Chinese Teacher MC2 STEM High School - Cleveland, OH
Chinese Teacher Warrensville Heights High School - Warrensville Heights, OH
Intern Gongyi Middle school - Hangzhou, CN
Chinese Teacher and little reporter Supervisor
Volunteer Chinese Teacher MC2 STEM High School - Cleveland, OH
Chinese Teacher Warrensville Heights High School - Warrensville Heights, OH
Intern Gongyi Middle school - Hangzhou, CN
Chinese Teacher and little reporter Supervisor
Education:
College of Education and Human Services, Cleveland State University - Cleveland, OH
Master in Curriculum Design and Instruction Zhejiang University - Hangzhou, CN
Master in Theory of Literature and Art Soochow University - Suzhou, CN
Bachelor of Arts in Chinese Language and Literature
Master in Curriculum Design and Instruction Zhejiang University - Hangzhou, CN
Master in Theory of Literature and Art Soochow University - Suzhou, CN
Bachelor of Arts in Chinese Language and Literature
Expression Of Fusion Polypeptides Transported Out Of The Cytoplasm Without Leader Sequences
US Patent:
5629172, May 13, 1997
Filed:
Aug 2, 1994
Appl. No.:
8/284784
Inventors:
Desmond Mascarenhas - Sunnyvale CA
Yang Zhang - Sunnyvale CA
Pamela S. Olson - Cupertino CA
David R. Olsen - Menlo Park CA
Pedro A. Cohen - San Francisco CA
Yang Zhang - Sunnyvale CA
Pamela S. Olson - Cupertino CA
David R. Olsen - Menlo Park CA
Pedro A. Cohen - San Francisco CA
Assignee:
Celtrix Pharmaceuticals, Inc. - Santa Clara CA
International Classification:
C12N 119, C12N 1562, C07K 1400
US Classification:
435 647
Abstract:
The invention is directed to the use of a fusion partner that does not contain a leader sequence, as a means to increase the solubility and activity of recombinant polypeptides by facilitating the expression of fusion proteins, which are then transported out of the cytoplasm. The invention includes a nucleic acid encoding a fusion polypeptide comprising a mature interleukin-1-like polypeptide or a leader-deleted-translocating polypeptide, and a polypeptide of interest; as well as host cells comprising such nucleic acids, and fusion proteins so encoded. The invention also encompasses methods of using such nucleic acids to produce recombinant fusion polypeptides, mature polypeptides of interest, and purified compositions thereof.
Expression Of Fusion Polypeptides Transported Out Of The Cytoplasm Without Leader Sequences
US Patent:
5914254, Jun 22, 1999
Filed:
May 12, 1997
Appl. No.:
8/854811
Inventors:
Desmond Mascarenhas - Los Altos Hills CA
Yang Zhang - Sunnyvale CA
Pamela S. Olson - Cupertino CA
David R. Olsen - Menlo Park CA
Pedro A. Cohen - San Francisco CA
Kimyen B. Nguyen - Union City CA
Yang Zhang - Sunnyvale CA
Pamela S. Olson - Cupertino CA
David R. Olsen - Menlo Park CA
Pedro A. Cohen - San Francisco CA
Kimyen B. Nguyen - Union City CA
Assignee:
Celtrix Pharmaceuticals, Inc. - Santa Clara CA
International Classification:
C07K 1900, C12N 1562
US Classification:
435 697
Abstract:
The invention is directed to the use of a fusion partner that does not contain a leader sequence, as a means to increase the solubility and activity of recombinant polypeptides by facilitating the expression of fusion proteins, which are then transported out of the cytoplasm. The invention includes a nucleic acid encoding a fusion polypeptide comprising a mature interleukin-1-like polypeptide or a leader-deleted-translocating polypeptide, and a polypeptide of interest; as well as host cells comprising such nucleic acids, and fusion proteins so encoded. The invention also encompasses methods of using such nucleic acids to produce recombinant fusion polypeptides, mature polypeptides of interest, and purified compositions thereof.
Polypeptide Fusions To Polypeptides Of The Beta-Trefoil Fold Structural Family
US Patent:
5830706, Nov 3, 1998
Filed:
Jun 5, 1995
Appl. No.:
8/460915
Inventors:
Desmond Mascarenhas - San Rafael CA
Yang Zhang - Sunnyvale CA
Pamela S. Olson - Cupertino CA
David R. Olsen - Menlo Park CA
Pedro A. Carrillo - San Francisco CA
Yang Zhang - Sunnyvale CA
Pamela S. Olson - Cupertino CA
David R. Olsen - Menlo Park CA
Pedro A. Carrillo - San Francisco CA
Assignee:
Celtrix Pharmaceuticals, Inc. - Santa Clara CA
International Classification:
C07K 1900, C12N 1562
US Classification:
435 697
Abstract:
The invention is directed to the use of IL-1-like fusion polypeptides to increase the solubility and activity of recombinant polypeptides. The invention includes a nucleic acid encoding a fusion polypeptide comprising an interleukin-1-like polypeptide and a polypeptide of interest and the method of using such a nucleic acid to produce recombinant fusion polypeptides.
Fusion Polypeptides And Proteins
US Patent:
5563046, Oct 8, 1996
Filed:
Aug 2, 1993
Appl. No.:
8/100744
Inventors:
Desmond Mascarenhas - San Rafael CA
Yang Zhang - Sunnyvale CA
Pamela S. Olson - Cupertino CA
David R. Olsen - Menlo Park CA
Pedro A. Carrillo - San Francisco CA
Yang Zhang - Sunnyvale CA
Pamela S. Olson - Cupertino CA
David R. Olsen - Menlo Park CA
Pedro A. Carrillo - San Francisco CA
Assignee:
Celtrix Pharmaceuticals, Inc. - Santa Clara CA
International Classification:
C07K 14245, C07K 14545, C12N 1562
US Classification:
435 6952
Abstract:
The invention is directed to the use of IL-1-like fusion polypeptides to increase the solubility and activity of recombinant polypeptides. The invention includes a nucleic acid encoding a fusion polypeptide comprising an interleukin-1-like polypeptide and a polypeptide of interest and the method of using such a nucleic acid to produce recombinant fusion polypeptides.